BlackRock Inc. acquired a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 5,431,818 shares of the medical technology company's stock, valued at approximately $688,537,000. BlackRock Inc. owned about 12.27% of Teleflex as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently modified their holdings of TFX. Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in shares of Teleflex by 227.5% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company's stock worth $3,395,000 after buying an additional 19,327 shares in the last quarter. First Eagle Investment Management LLC lifted its position in Teleflex by 163.4% during the fourth quarter. First Eagle Investment Management LLC now owns 84,300 shares of the medical technology company's stock worth $10,288,000 after acquiring an additional 52,300 shares during the last quarter. Baader Bank Aktiengesellschaft boosted its position in shares of Teleflex by 32.4% in the fourth quarter. Baader Bank Aktiengesellschaft now owns 43,333 shares of the medical technology company's stock valued at $5,288,000 after acquiring an additional 10,600 shares during the period. Diamond Hill Capital Management Inc. grew its position in Teleflex by 6.3% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 349,809 shares of the medical technology company's stock worth $42,691,000 after buying an additional 20,773 shares in the last quarter. Finally, Fifth Third Bancorp grew its stake in Teleflex by 3,204.8% during the first quarter. Fifth Third Bancorp now owns 68,144 shares of the medical technology company's stock worth $8,151,000 after buying an additional 66,082 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the company. Zacks Research upgraded Teleflex from a "strong sell" rating to a "hold" rating in a research report on Tuesday, April 28th. Weiss Ratings restated a "sell (d)" rating on shares of Teleflex in a report on Wednesday, June 24th. Needham & Company LLC lifted their price target on Teleflex from $147.00 to $159.00 and gave the stock a "buy" rating in a report on Friday, July 31st. UBS Group increased their target price on shares of Teleflex from $145.00 to $158.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 11th. Finally, Wall Street Zen raised shares of Teleflex from a "sell" rating to a "hold" rating in a report on Sunday, August 9th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Teleflex currently has an average rating of "Hold" and an average price target of $151.80.
Get Our Latest Analysis on Teleflex
Teleflex Stock Up 0.1%
Shares of NYSE:TFX opened at $138.99 on Monday. The stock has a fifty day simple moving average of $132.70 and a two-hundred day simple moving average of $124.88. The stock has a market capitalization of $5.89 billion, a price-to-earnings ratio of -5.97, a PEG ratio of 0.93 and a beta of 0.81. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $145.00. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.28 by $0.48. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The company had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. During the same period last year, the company earned $3.73 EPS. Teleflex's revenue for the quarter was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, research analysts anticipate that Teleflex Incorporated will post 7.26 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th. Teleflex's payout ratio is -5.84%.
About Teleflex
(
Free Report)
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Further Reading
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.